The Catalysis Foundation for Health, Inc. is a 501 (c) (3) non-profit private operating foundation directing scientific and healthcare research resources to help alleviate the gap in global healthcare caused by improper or unavailable disease diagnosis and monitoring technologies.

Halteres is a biotechnology and diagnostics consultancy, specializing in product, market and business development and strategic planning for a wide variety of companies, from early start ups to multinational corporations and foundations. Focus areas include strategy, business, technology, product and market assessments and product commercialization in both developed and developing markets. Projects have included due diligence analyses and risk assessments for venture groups, business and product development projects for start-up and early stage companies, market and technology assessments for a variety of organizations and global commercialization and post market support requirements.

Vice President, Head Business Development (2005-2006)Reported to the SVP, Global Marketing and Business Development*Led identification and evaluation of business development opportunities, provided business direction for the licensing and industrial business functions, health economics and other pre-marketing functions, and the pharmaceutical and service lab industry liaisons *Drafted the first comprehensive 10-year strategy for RMD, assessing the overall molecular diagnostics market and recommending portfolio investments to meet unmet market needsVice President, Head Blood Screening Business Unit (2002-2005)Reported to the SVP, Global Marketing and Business Development*Managed growth of the blood screening business from $100 million to over $260 million, exceeding plan and becoming the leading nucleic acid-based blood screening company with operations in over 30 countries*Set business, product, and marketing strategies, exceeded P&L objectives, led business development, and provided direction for product development *Oversaw the development and launch, in record time, of the world’s first nucleic acid test for screening blood for West Nile Virus*Directly managed 7 reports and matrix-managed a multi-national team, including members from research, development, and instrumentation, with annual R&D budgets exceeding $50 million and M&D budgets exceeding $30 million*Interacted directly with international authorities, Roche Affiliate organizations, and key customers on strategies and market needs and presented at international congresses

Co-Founder, Chief Financial Officer and Vice President of OperationsGeneral Manager, CFO, Treasurer, and member of the Board of Directors, reporting to the President and CEOGeneral Management*Managed general corporate, legal, financial, and accounting matters*Knowledgeable in technical, production, and program issues, including requirements for assay and systems product developmentBusiness and Market Development *Wrote company’s business plan and worked with the Board of Directors to reach agreement on the business and marketing strategy*Managed business development activities, including detailed discussions with U.S., European, and Japanese diagnostic, pharmaceutical and distribution companies regarding strategic alliances and distribution dealsOperations*Set up pilot manufacturing and prepared manufacturing plan for large scale production, including equipment, facilities, and personnel requirements, cost models, and lead times Financial, Legal, Patents and Regulatory*Worked with outside counsel to incorporate the company, set up stock and stock option plans*Closed Series A and initial Series B financing rounds*Established worldwide intellectual property strategy as driver for R&D strategy and drafted multiple patent applications, resulting in two issued patents and others pending*Prepared company’s 510(k) submission and was responsible for all FDA interactions, culminating with product approval in under 90 days

Director, Blood Screening and Infectious Disease Business Unit (1995-1998)Directed Programs and Project Management and reported to the SVP, Infectious Disease Business Unit, which developed and manufactured infectious disease products for sale in the worldwide clinical diagnostics and blood screening industries.*Set and managed program goals, priorities, and budgets for over 200 team members and 8 reports, and managed product development and manufacturing programs for a continuously evolving mix of over 60 antigens and assays, generating 1996 revenues to Chiron of $95 million*Led business development, strategic planning, and resource management to insure the business retained its dominant position in the blood screening market *Managed relationships and daily interactions with large multi-national corporations including Johnson & Johnson and Abbott Laboratories*Responsible for a $30 million instrument development and manufacturing program Associate Director / Project Manager (1992-1994)Product Development Manager / Regulatory Associate (1987-1991)Laboratory Supervisor / Research Associate (1984-1987)*Managed interactions and efficient transfer of technology and information between R&D, Manufacturing, QA, QC, Operations, Regulatory, Clinical, and Marketing*Gained comprehensive experience assessing reagent systems for manufacturability and reliability. *Created multi-disciplinary project teams responsible for developing and manufacturing the first diagnostic products to be launched by Chiron: 1st and 2nd generation hepatitis C virus assays *Managed regulatory associates and actively prepared FDA submissions *Supervised DNA Cloning and Sequencing Laboratory *Member of the Hepatitis C virus discovery team, developed and published improved cloning and sequencing techniques and worked with Applied Biosystems and DuPont to evaluate the first prototype DNA sequencing instruments